WallStreetZenWallStreetZen

NASDAQ: MBAI
Mbody Ai Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MBAI

Based on 1 analyst offering 12 month price targets for Mbody Ai Ltd

Min Forecast
$10.00+378.47%
Avg Forecast
$10.00+378.47%
Max Forecast
$10.00+378.47%

Should I buy or sell MBAI stock?

Based on 1 analyst offering ratings for Mbody Ai Ltd.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MBAI stock forecasts and price targets.

MBAI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-28

1 of 1

Forecast return on equity

Is MBAI forecast to generate an efficient return?

Company
5.66%
Industry
348.64%
Market
154.98%
MBAI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MBAI forecast to generate an efficient return on assets?

Company
2.6%
Industry
11.92%
MBAI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MBAI earnings per share forecast

What is MBAI's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.02-100.44%
Avg 2 year Forecast
$0.00-100%
Avg 3 year Forecast
$0.19-95.81%
MBAI's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

MBAI revenue forecast

What is MBAI's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$4.9M
Avg 2 year Forecast
$16.1M
Avg 3 year Forecast
$27.9M

MBAI earnings growth forecast

How is MBAI forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
-88.81%
Industry
22.83%
Market
66.02%
MBAI's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MBAI's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MBAI's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MBAI vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
MBAI$2.09$10.00+378.47%Buy
ISPC$0.79N/AN/A
BIAF$3.03N/AN/A
VNRX$0.20$4.00+1,920.20%Strong Buy
MDXH$0.18$2.25+1,143.09%Strong Buy
View Top Diagnostic & Research Stocks

Mbody Ai Stock Forecast FAQ

Is Mbody Ai Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MBAI) stock is to Buy MBAI stock.

Out of 1 analyst, 0 (0%) are recommending MBAI as a Strong Buy, 1 (100%) are recommending MBAI as a Buy, 0 (0%) are recommending MBAI as a Hold, 0 (0%) are recommending MBAI as a Sell, and 0 (0%) are recommending MBAI as a Strong Sell.

If you're new to stock investing, here's how to buy Mbody Ai stock.

What is MBAI's earnings growth forecast for 2026-2028?

(NASDAQ: MBAI) Mbody Ai's forecast annual earnings growth rate of -88.81% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 22.83%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 66.02%.

Mbody Ai's earnings in 2026 is $4,140,000.On average, 3 Wall Street analysts forecast MBAI's earnings for 2026 to be -$20,460, with the lowest MBAI earnings forecast at -$19,657, and the highest MBAI earnings forecast at -$21,062. On average, 3 Wall Street analysts forecast MBAI's earnings for 2027 to be $0, with the lowest MBAI earnings forecast at $0, and the highest MBAI earnings forecast at $0.

In 2028, MBAI is forecast to generate $194,368 in earnings, with the lowest earnings forecast at $186,745 and the highest earnings forecast at $200,084.

What is MBAI's revenue growth forecast for 2026-2028?

(NASDAQ: MBAI) Mbody Ai's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.88%.

Mbody Ai's revenue in 2026 is $0.On average, 3 Wall Street analysts forecast MBAI's revenue for 2026 to be $4,869,220, with the lowest MBAI revenue forecast at $4,678,664, and the highest MBAI revenue forecast at $5,012,639. On average, 3 Wall Street analysts forecast MBAI's revenue for 2027 to be $16,132,113, with the lowest MBAI revenue forecast at $15,500,268, and the highest MBAI revenue forecast at $16,607,501.

In 2028, MBAI is forecast to generate $28,009,801 in revenue, with the lowest revenue forecast at $26,910,591 and the highest revenue forecast at $28,833,206.

What is MBAI's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: MBAI) forecast ROA is 2.6%, which is lower than the forecast US Diagnostics & Research industry average of 11.92%.

What is MBAI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MBAI price target, the average MBAI price target is $10.00, with the highest MBAI stock price forecast at $10.00 and the lowest MBAI stock price forecast at $10.00.

The Wall Street analyst predicted that Mbody Ai's share price could reach $10.00 by Sep 28, 2027. The average Mbody Ai stock price prediction forecasts a potential upside of 378.47% from the current MBAI share price of $2.09.

What is MBAI's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MBAI) Mbody Ai's current Earnings Per Share (EPS) is $4.62. On average, analysts forecast that MBAI's EPS will be -$0.02 for 2026, with the lowest EPS forecast at -$0.02, and the highest EPS forecast at -$0.02. On average, analysts forecast that MBAI's EPS will be $0.00 for 2027, with the lowest EPS forecast at $0.00, and the highest EPS forecast at $0.00. In 2028, MBAI's EPS is forecast to hit $0.19 (min: $0.19, max: $0.20).

What is MBAI's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: MBAI) forecast ROE is 5.66%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.